Bridgewater Associates - SEATTLE GENETICS INC ownership

SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 271 filers reported holding SEATTLE GENETICS INC in Q3 2017. The put-call ratio across all filers is 1.45 and the average weighting 0.3%.

Quarter-by-quarter ownership
Bridgewater Associates ownership history of SEATTLE GENETICS INC
ValueSharesWeighting
Q2 2019$515,000
-58.1%
7,437
-68.3%
0.00%
-66.7%
Q1 2018$1,228,000
-77.8%
23,470
-78.0%
0.01%
-76.5%
Q2 2017$5,524,000
-35.8%
106,760
-34.5%
0.05%
-37.8%
Q4 2016$8,607,000
+520.1%
163,107
+353.1%
0.08%
+331.6%
Q3 2015$1,388,000
+508.8%
36,000
+486.3%
0.02%
+850.0%
Q3 2014$228,000
-77.7%
6,140
-72.6%
0.00%
-75.0%
Q1 2014$1,021,00022,4000.01%
Other shareholders
SEATTLE GENETICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Lagoda Investment Management, L.P. 57,170$10,013,0005.39%
Boxer Capital, LLC 400,000$70,056,0002.25%
PARTNERS CAPITAL INVESTMENT GROUP, LLP 110,153$19,292,0001.10%
DCF Advisers, LLC 13,300$2,329,0000.96%
XTX MARKETS LLC 2,418$423,0000.87%
FAIRFIELD, BUSH & CO. 15,035$2,633,0000.77%
Parcion Private Wealth LLC 4,520$792,0000.10%
Gulf International Bank (UK) Ltd 26,091$4,569,0000.06%
Princeton Portfolio Strategies Group LLC 1,500$263,0000.05%
Redpoint Investment Management Pty Ltd 2,392$419,0000.04%
View complete list of SEATTLE GENETICS INC shareholders